Press Release – 09.01.2018

The French HealthTech Theraclion presents its Echopulse at CES 2018

The Echopulse for tumor treatment by ultrasound with real-time ultrasound imaging will be presented on the Focused Ultrasound Foundation’s, booth NL-1

 

Theraclion announced the presence of its Echopulse devices at CES 2018 in Las Vegas on the stand of its American partner Focused Utrasound Foundation (booth NL-1).

 

CES, showcases more than 3,900 exhibiting companies, including manufacturers, developers and suppliers of consumer technology hardware, content, technology delivery systems and more; a conference program with more than 300 conference sessions and more than 170K attendees from 150 countries.

 

CES 2018 takes place from January 9-12th in Las Vegas.

 

Read the press release

Print Friendly, PDF & Email